Joanne Xiu

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Joanne Xiu
Mar 19, 2025, 08:44 | Blog
Joanne Xiu: Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals
Joanne Xiu, Vice President, Clinical and Translational Research at Caris Life Sciences, posted on LinkedIn…
Jan 22, 2025, 10:25 | Blog
Molecular profiling of sqNSCLC reveals high incidence of actionable genomic alterations among patients with no history of smoking
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X: "Comprehensive profiling…
Jan 21, 2025, 14:15 | Science
Distinct molecular and clinical features of KRAS G12 mutations in Pancreatic Cancer
Jash Datta, Associate Professor at University of Miami’s Miller School of Medicine, posted on X…
Jan 20, 2025, 16:03 | Science
Amy Moore: Biomarker testing can help identify actionable mutations in patients with squamous NSCLC
Amy Moore, Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation, shared a…
Nov 30, 2024, 09:12 | Blog
USC Norris Study Explores Mechanisms of Innate Resistance to Immunotherapies in Colorectal Cancer
Researchers at the USC Norris Comprehensive Cancer Center have discovered that targeting both the innate…
Nov 25, 2024, 17:49 | Insight
Tejas Patil: Why biomarkers like PDL1 and TMB aren’t always associated with ‘hot’ or ‘cold’ immune TME
Tejas Patil, Thoracic oncologist CU Cancer Center, shared a post by Cancer Cell on X:…
Nov 24, 2024, 13:09 | Opinion
Pashtoon Kasi: One biomarker that you cannot miss is MSI-High or dMMR
Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, shared a post…
Nov 24, 2024, 02:10 | Blog
Joanne Xiu: The complexity of biomarkers associated with Anti-PD-1/L1 Therapy Outcomes
Joanne Xiu, Vice President, Clinical and Translational Research at Caris Life Sciences, posted on LinkedIn…
Nov 2, 2024, 19:25 | Insight
Health Disparities in Cancer Patients Receiving Molecular Testing for Biomarker - Directed Therapy
Estela Rodriguez shared on X: "Health Disparities among Patients with Cancer Who Received Molecular Testing for…
Sep 10, 2024, 11:17 | Insight
Jennifer Marks: Our MET-working paper in collaboration with Caris Life Sciences
Jennifer Marks shared a post on X: “Our MET-working paper in collaboration with Caris Life…
Sep 7, 2024, 07:32 | Insight
5 papers about lung cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Aug 14, 2024, 13:18 | Insight
Thejus Jayakrishnan: Multiomic analysis of early onset biliary tract cancer
Thejus Jayakrishnan, Hematology/Oncology Fellow at Cleveland Clinic, shared a post by Alok Khorana, Professor of Medicine at Cleveland…
Aug 9, 2024, 07:05 | Blog
Molecular differences in early-onset biliary tract cancer
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, posted on X about…
May 17, 2024, 17:53 | Insight
Piotr Wysocki: Better responses to immunotherapy in NSCLC patients with rare EGFR mutation
Piotr Wysocki recently posted on LinkedIn: "The efficacy of immune checkpoint inhibitors (ICI) as monotherapy in…
All: 14 Posts: 1 - 100
Special Coverage